Hiroshi Ishiba

1.1k total citations
18 papers, 560 citations indexed

About

Hiroshi Ishiba is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hiroshi Ishiba has authored 18 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Hiroshi Ishiba's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Hiroshi Ishiba is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Hiroshi Ishiba collaborates with scholars based in Japan and United States. Hiroshi Ishiba's co-authors include Yuya Seko, Kanji Yamaguchi, Yoshito Itoh, Michihisa Moriguchi, Kohichiroh Yasui, Akira Okajima, Yoshio Sumida, Hiroyoshi Taketani, Tasuku Hara and Atsushi Umemura and has published in prestigious journals such as Scientific Reports, Laboratory Investigation and Liver International.

In The Last Decade

Hiroshi Ishiba

17 papers receiving 551 citations

Peers

Countries citing papers authored by Hiroshi Ishiba

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Ishiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ishiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ishiba more than expected).

Fields of papers citing papers by Hiroshi Ishiba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ishiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ishiba. The network helps show where Hiroshi Ishiba may publish in the future.

Co-authorship network of co-authors of Hiroshi Ishiba

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ishiba. A scholar is included among the top collaborators of Hiroshi Ishiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ishiba. Hiroshi Ishiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

#	Work	Indexed citations
1	Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction 2024 ·Scientific Reports ·(unknown), Kanji Yamaguchi, Yusuke Takahashi, (unknown), (unknown), Hiroshi Ishiba, Nozomi Tochiki, Seita Kataoka, Hideki Fujii, N. Iwai, Yuya Seko, Atsushi Umemura, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh	7
2	[A case report:the progress of fascioliasis from hepatic phase to biliary phase]. 2023 ·PubMed ·(unknown), Akihito Harusato, (unknown), (unknown), Hiroshi Ishiba, Akifumi Fukui, Tatsushi Omatsu, Tetsuya Okayama, Osamu Satoh, Tetsuya Imura, (unknown), Kazuhiro Katada, Yoshito Itoh	0
3	Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice 2021 ·Laboratory Investigation ·(unknown), Kanji Yamaguchi, Yuya Seko, (unknown), Hiroshi Ishiba, Nozomi Tochiki, Aya Takahashi, Seita Kataoka, Keiichiroh Okuda, Yu Liu, Hideki Fujii, Atsushi Umemura, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh	42
4	Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 2020 ·Diagnostics ·Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima, (unknown)	23
5	PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat 2020 ·Scientific Reports ·(unknown), Kanji Yamaguchi, Hiroshi Ishiba, Nozomi Tochiki, (unknown), Aya Takahashi, Seita Kataoka, Keiichiroh Okuda, Yuya Seko, Yu Liu, Hideki Fujii, Daiki Takahashi, Yusuke Ito, Junji Kamon, Atsushi Umemura, Michihisa Moriguchi, Kohichiroh Yasui, Takeshi Okanoue, Yoshito Itoh	14
6	<p>Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice</p> 2019 ·Diabetes Metabolic Syndrome and Obesity ·Hiroyoshi Taketani, Taichiro Nishikawa, Hisakazu Nakajima, Kazuki Kodo, Satoru Sugimoto, Wataru Aoi, Shin‐ichi Horike, Makiko Meguro‐Horike, Hiroshi Ishiba, Yuya Seko, Atsushi Umemura, Kanji Yamaguchi, Michihisa Moriguchi, Kohichiroh Yasui, Yoshito Itoh	5
7	Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease 2017 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Kazuyuki Kanemasa, Kohichiroh Yasui, Shunsuke Imai, Keiji Shimada, Yoshito Itoh	23
8	Hepatic nucleotide binding oligomerization domain‐like receptors pyrin domain‐containing 3 inflammasomes are associated with the histologic severity of non‐alcoholic fatty liver disease 2017 ·Hepatology Research ·Hironori Mitsuyoshi, Kohichiroh Yasui, Tasuku Hara, Hiroyoshi Taketani, Hiroshi Ishiba, Akira Okajima, Yuya Seko, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Masahito Minami, Yoshito Itoh	24
9	Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression 2016 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Kazuyuki Kanemasa, Kohichiroh Yasui, Shunsuke Imai, Keiji Shimada, Yoshito Itoh	62
10	Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus 2016 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Kazuyuki Kanemasa, Kohichiroh Yasui, Shunsuke Imai, Keiji Shimada, Yoshito Itoh	79
11	Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non‐alcoholic fatty liver disease 2016 ·Hepatology Research ·Akira Okajima, Yoshio Sumida, Hiroyoshi Taketani, Tasuku Hara, Yuya Seko, Hiroshi Ishiba, Takeshi Nishimura, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh	16
12	Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus 2016 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Kazuyuki Kanemasa, Kohichiroh Yasui, Shunsuke Imai, Keiji Shimada, Yoshito Itoh	67
13	Association of coronary artery calcification with liver fibrosis in Japanese patients with non‐alcoholic fatty liver disease 2016 ·Hepatology Research ·Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Ki-ichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko, Akira Okajima, Tasuku Hara, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Yoshito Itoh	20
14	Drug‐induced liver injury in a chronic hepatitis C patient treated by peginterferon, ribavirin and simeprevir 2015 ·Hepatology Research ·Akira Okajima, Kanji Yamaguchi, Hiroyoshi Taketani, Tasuku Hara, Hiroshi Ishiba, Yuya Seko, Takeshi Nishimura, Taichiro Nishikawa, Hideki Fujii, Michihisa Moriguchi, Hironori Mitsuyoshi, Yoshio Sumida, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh	3
15	Predictors of malignancies and overall mortality in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease 2014 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hiroyoshi Taketani, Kazuyuki Kanemasa, Hiroshi Ishiba, Akira Okajima, Takeshi Nishimura, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh	23
16	Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in Japanese patients 2014 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kazuyuki Kanemasa, Kohichiroh Yasui, Masahito Minami, Shunsuke Imai, Yoshito Itoh	46
17	Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high‐fat diet fed mice 2014 ·Liver International ·Kanji Yamaguchi, Takeshi Nishimura, Hiroshi Ishiba, Yuya Seko, Akira Okajima, Hideki Fujii, Nozomi Tochiki, Atsushi Umemura, Michihisa Moriguchi, Yoshio Sumida, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Takeshi Okanoue, Yoshito Itoh	36
18	Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease 2014 ·Hepatology Research ·Yoshio Sumida, Yoshikazu Yonei, Saiyu Tanaka, Kojiroh Mori, Kazuyuki Kanemasa, Shunsuke Imai, Hiroyoshi Taketani, Tasuku Hara, Yuya Seko, Hiroshi Ishiba, Akira Okajima, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh	70

Work

Indexed citations

Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction

2024 ·Scientific Reports ·(unknown), Kanji Yamaguchi, Yusuke Takahashi, (unknown), (unknown), Hiroshi Ishiba, Nozomi Tochiki, Seita Kataoka, Hideki Fujii, N. Iwai, Yuya Seko, Atsushi Umemura, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh

[A case report:the progress of fascioliasis from hepatic phase to biliary phase].

2023 ·PubMed ·(unknown), Akihito Harusato, (unknown), (unknown), Hiroshi Ishiba, Akifumi Fukui, Tatsushi Omatsu, Tetsuya Okayama, Osamu Satoh, Tetsuya Imura, (unknown), Kazuhiro Katada, Yoshito Itoh

Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice

2021 ·Laboratory Investigation ·(unknown), Kanji Yamaguchi, Yuya Seko, (unknown), Hiroshi Ishiba, Nozomi Tochiki, Aya Takahashi, Seita Kataoka, Keiichiroh Okuda, Yu Liu, Hideki Fujii, Atsushi Umemura, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

2020 ·Diagnostics ·Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima, (unknown)

PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat

2020 ·Scientific Reports ·(unknown), Kanji Yamaguchi, Hiroshi Ishiba, Nozomi Tochiki, (unknown), Aya Takahashi, Seita Kataoka, Keiichiroh Okuda, Yuya Seko, Yu Liu, Hideki Fujii, Daiki Takahashi, Yusuke Ito, Junji Kamon, Atsushi Umemura, Michihisa Moriguchi, Kohichiroh Yasui, Takeshi Okanoue, Yoshito Itoh

<p>Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice</p>

2019 ·Diabetes Metabolic Syndrome and Obesity ·Hiroyoshi Taketani, Taichiro Nishikawa, Hisakazu Nakajima, Kazuki Kodo, Satoru Sugimoto, Wataru Aoi, Shin‐ichi Horike, Makiko Meguro‐Horike, Hiroshi Ishiba, Yuya Seko, Atsushi Umemura, Kanji Yamaguchi, Michihisa Moriguchi, Kohichiroh Yasui, Yoshito Itoh

Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease

2017 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Kazuyuki Kanemasa, Kohichiroh Yasui, Shunsuke Imai, Keiji Shimada, Yoshito Itoh

Hepatic nucleotide binding oligomerization domain‐like receptors pyrin domain‐containing 3 inflammasomes are associated with the histologic severity of non‐alcoholic fatty liver disease

2017 ·Hepatology Research ·Hironori Mitsuyoshi, Kohichiroh Yasui, Tasuku Hara, Hiroyoshi Taketani, Hiroshi Ishiba, Akira Okajima, Yuya Seko, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Masahito Minami, Yoshito Itoh

Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression

2016 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Kazuyuki Kanemasa, Kohichiroh Yasui, Shunsuke Imai, Keiji Shimada, Yoshito Itoh

Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus

Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non‐alcoholic fatty liver disease

2016 ·Hepatology Research ·Akira Okajima, Yoshio Sumida, Hiroyoshi Taketani, Tasuku Hara, Yuya Seko, Hiroshi Ishiba, Takeshi Nishimura, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh

Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus

Association of coronary artery calcification with liver fibrosis in Japanese patients with non‐alcoholic fatty liver disease

2016 ·Hepatology Research ·Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Ki-ichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko, Akira Okajima, Tasuku Hara, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Yoshito Itoh

Drug‐induced liver injury in a chronic hepatitis C patient treated by peginterferon, ribavirin and simeprevir

2015 ·Hepatology Research ·Akira Okajima, Kanji Yamaguchi, Hiroyoshi Taketani, Tasuku Hara, Hiroshi Ishiba, Yuya Seko, Takeshi Nishimura, Taichiro Nishikawa, Hideki Fujii, Michihisa Moriguchi, Hironori Mitsuyoshi, Yoshio Sumida, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh

Predictors of malignancies and overall mortality in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease

2014 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hiroyoshi Taketani, Kazuyuki Kanemasa, Hiroshi Ishiba, Akira Okajima, Takeshi Nishimura, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh

Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in Japanese patients

2014 ·Hepatology Research ·Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kazuyuki Kanemasa, Kohichiroh Yasui, Masahito Minami, Shunsuke Imai, Yoshito Itoh

Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high‐fat diet fed mice

2014 ·Liver International ·Kanji Yamaguchi, Takeshi Nishimura, Hiroshi Ishiba, Yuya Seko, Akira Okajima, Hideki Fujii, Nozomi Tochiki, Atsushi Umemura, Michihisa Moriguchi, Yoshio Sumida, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Takeshi Okanoue, Yoshito Itoh

Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease

2014 ·Hepatology Research ·Yoshio Sumida, Yoshikazu Yonei, Saiyu Tanaka, Kojiroh Mori, Kazuyuki Kanemasa, Shunsuke Imai, Hiroyoshi Taketani, Tasuku Hara, Yuya Seko, Hiroshi Ishiba, Akira Okajima, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh

Hiroshi Ishiba

About

In The Last Decade

Hiroshi Ishiba

Peers

Countries citing papers authored by Hiroshi Ishiba

Fields of papers citing papers by Hiroshi Ishiba

Co-authorship network of co-authors of Hiroshi Ishiba

All Works

Explore authors with similar magnitude of impact